WINTON GROUP Ltd - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$374,844
+37.5%
14,671
+54.3%
0.03%
+34.8%
Q2 2023$272,661
+22.3%
9,507
+103.9%
0.02%
+91.7%
Q3 2021$223,000
-41.0%
4,663
-58.2%
0.01%
-40.0%
Q2 2021$378,000
-14.1%
11,164
+4.7%
0.02%
-20.0%
Q1 2021$440,00010,6640.02%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders